146062-67-1

Basic information

• Product Name: methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate
• Synonyms: methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate
• CAS NO: 146062-67-1
• Molecular Weight: 403.275
• Mol File: 146062-67-1.mol

Chemical Properties

• CAS DataBase Reference: methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate(146062-67-1)
• EPA Substance Registry System: methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate(146062-67-1)

Safety Data

• Hazardous Substances Data: 146062-67-1(Hazardous Substances Data)

Upstream product

• 1317-39-1 copper(I) oxide 
• 292638-85-8 acrylic acid methyl ester 
• 146062-66-0 5-cyanomethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 146062-63-7 5-methoxymethoxymethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 146062-65-9 5-chloromethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 146062-64-8 5-hydroxymethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 146062-62-6 2-(5-((methoxymethoxy)methyl)-2-pyridyl)ethanol 
• 146062-61-5 3-((methoxymethoxy)methyl)-6-methylpyridine 
• 5470-70-2 Methyl 6-methylnicotinate 
• 34107-46-5 6-methyl-3-pyridinemethanol 
• 1026751-32-5 {6-[2-(4-Amino-phenoxy)-ethyl]-pyridin-3-yl}-acetonitrile 

Downstream Products

• 146062-68-2 5-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>benzyl>-2-imino-4-thiazolidinone 
• 146062-48-8 (+/-)-5-benzyl>-2,4-thiazolinedione 

Relevant articles and documents

Thiazolidinedione derivatives, production and use thereof

A thiazolidinedione compound of the formula STR1 wherein X,Q are as defined in the specification. The compounds are used for treating diabetes.

Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (±)-5-[p-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone)

The metabolites of (±)-5-[p-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (1, pioglitazone), which is a representative insulin- sensitizing agent, were synthesized to confirm their structures and for studies of their pharmacological properti